Press Release

MicroFab receives SBIR award from National Institute of Health for the development of an ink-jet based system for Western blot studies.

Plano, Texas (September 3, 2006)

MicroFab Technologies announces the award of a NIH Phase I SBIR program entitled, “Micro-Western Blot for Proteomics Studies”. This Small Business Innovation Research Phase I project has the objective of designing and building an ink-jet based system for the microdeposition of multiple phosphorylation site-specific antibodies onto protein bands of 1D or spots of 2D SDS-PAGE blots in the performance of protein phosphorylation studies. This new method has the significant advantage of examining for the presence and specific phosphorylation status of many proteins contained within one protein blot. This process is more rapid, consumes significantly less antibody, requires a fewer number of gels and blots, and conserves precious protein samples. In circumstances where a protein sample is limited or the source of the antibody is rare or expensive, the Micro-Western blot method provides a powerful alternative to conventional Western blotting methods.

About the Company

Based in Plano, Texas, MicroFab Technologies has pioneered digital microdispensing technologies for the past 18 years. MicroFab’s mission is to be the leading global supplier of printing platforms, devices, and services that enable high-payoff applications for microdispensing and precision printing in a wide range of industries. Commercial applications of the technology include microdispensing of electrical and optical polymers, bioactive materials (Proteins, DNA, Reagents), solder, adhesives, and nanoparticle laden fluids.

Contact Information

MicroFab Technologies is at www.microfab.com. Contact Dr. David B. Wallace, Vice-President, Technology Development, at microinfo3@microfab.com or by phone at 972-578-8076 (ext. 12).